BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

NCT02763384 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

T-Acute Lymphoblastic Leukemia
Adult T Lymphoblastic Lymphoma

Interventions

DRUG: BL-8040
DRUG: Nelarabine

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]